Literature DB >> 25736238

Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants.

S Guida1, N Bartolomeo, P T Zanna, C Grieco, I Maida, S De Summa, S Tommasi, M Guida, A Azzariti, C Foti, R Filotico, G Guida.   

Abstract

Environmental and genetic risk factors are involved in the development of melanoma. The role of the melanocortin 1 receptor (MC1R) gene has been investigated and differences according to geographic areas have been described. To evaluate the role of some clinical and genetic risk factors in melanoma development, we performed a case-control study involving 101 melanoma patients and 103 controls coming from South-Eastern Italy (Puglia), after achieving informed consent. We confirmed the role of known clinical risk factors for melanoma. Furthermore, 42 MC1R polymorphisms were observed. Three of these variants (L26V, H232L, D294Y) were not previously reported in the literature. Their predicted impact on receptor function was evaluated using bioinformatic tools. We report an overall frequency of MC1R variants in our population higher than in Northern or Central Italy. The most common polymorphism found was V60L, that has been recently reported to spread among South Mediterranean population. This variant influenced phenotypic characteristics of our population while it did not impinge on melanoma risk. An increased risk of melanoma was associated with two or more MC1R variants, when at least one was RHC, compared to people carrying the MC1R consensus sequence or a single MC1R polymorphism. Interestingly, we observed an increased risk of melanoma in subjects with darker skin and lower nevus count, usually considered at low risk, when carrying MC1R polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736238     DOI: 10.1007/s00403-015-1552-4

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  9 in total

1.  Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

Authors:  Jennifer L Hay; Kate Zielaskowski; Kirsten Meyer White; Kimberly Kaphingst; Erika Robers; Dolores Guest; Andrew Sussman; Yvonne Talamantes; Matthew Schwartz; Vivian M Rodríguez; Yuelin Li; Elizabeth Schofield; Jessica Bigney; Keith Hunley; David Buller; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

2.  Cutaneous pharmacologic cAMP induction induces melanization of the skin and improves recovery from ultraviolet injury in melanocortin 1 receptor-intact or heterozygous skin.

Authors:  Robert-Marlo Bautista; Katharine Marie Carter; Stuart Gordon Jarrett; Dana Napier; Kazumasa Wakamatsu; Shosuke Ito; John August D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2019-08-24       Impact factor: 4.693

3.  MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.

Authors:  Cristina Pellegrini; Francesca Botta; Daniela Massi; Claudia Martorelli; Fabio Facchetti; Sara Gandini; Patrick Maisonneuve; Marie-Françoise Avril; Florence Demenais; Brigitte Bressac-de Paillerets; Veronica Hoiom; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Loraine Marrett; Roberto Zanetti; Terence Dwyer; Nancy E Thomas; Colin B Begg; Marianne Berwick; Susana Puig; Miriam Potrony; Eduardo Nagore; Paola Ghiorzo; Chiara Menin; Ausilia Maria Manganoni; Monica Rodolfo; Sonia Brugnara; Emanuela Passoni; Lidija Kandolf Sekulovic; Federica Baldini; Gabriella Guida; Alexandros Stratigos; Fezal Ozdemir; Fabrizio Ayala; Ricardo Fernandez-de-Misa; Pietro Quaglino; Gloria Ribas; Antonella Romanini; Emilia Migliano; Ignazio Stanganelli; Peter A Kanetsky; Maria Antonietta Pizzichetta; Jose Carlos García-Borrón; Hongmei Nan; Maria Teresa Landi; Julian Little; Julia Newton-Bishop; Francesco Sera; Maria Concetta Fargnoli; Sara Raimondi
Journal:  Lancet Child Adolesc Health       Date:  2019-03-12

4.  The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response.

Authors:  Rosamaria Pinto; Simona De Summa; Sabino Strippoli; Brunella Pilato; Amalia Azzariti; Gabriella Guida; Michele Guida; Stefania Tommasi
Journal:  Oncotarget       Date:  2016-05-03

5.  MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.

Authors:  Elena Tagliabue; Sara Gandini; Rino Bellocco; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Maria Teresa Landi; Chiara Menin; Maria Concetta Fargnoli; Jose Carlos García-Borrón; Jiali Han; Julian Little; Francesco Sera; Sara Raimondi
Journal:  Cancer Manag Res       Date:  2018-05-14       Impact factor: 3.989

6.  Tomatine Displays Antitumor Potential in In Vitro Models of Metastatic Melanoma.

Authors:  Simona Serratì; Letizia Porcelli; Stefania Guida; Anna Ferretta; Rosa Maria Iacobazzi; Tiziana Cocco; Immacolata Maida; Gabriella Tamasi; Claudio Rossi; Michele Manganelli; Stefania Tommasi; Amalia Azzariti; Gabriella Guida
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

7.  MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.

Authors:  Saverio Caini; Sara Gandini; Francesca Botta; Elena Tagliabue; Sara Raimondi; Eduardo Nagore; Ines Zanna; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Rajiv Kumar; Peter A Kanetsky; Veronica Hoiom; Paola Ghiorzo; Maria Teresa Landi; Gloria Ribas; Chiara Menin; Alexander J Stratigos; Giuseppe Palmieri; Gabriella Guida; Jose Carlos García-Borrón; Hongmei Nan; Julian Little; Francesco Sera; Susana Puig; Maria Concetta Fargnoli
Journal:  Melanoma Res       Date:  2020-10       Impact factor: 3.199

8.  MC1R Is a Prognostic Marker and Its Expression Is Correlated with MSI in Colorectal Cancer.

Authors:  Lixiong Peng; Jiang Chang; Xilin Liu; Shiying Lu; Honglin Ren; Xiaoshi Zhou; Zengshan Liu; Pan Hu
Journal:  Curr Issues Mol Biol       Date:  2021-10-11       Impact factor: 2.976

Review 9.  Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.

Authors:  Michele Manganelli; Stefania Guida; Anna Ferretta; Giovanni Pellacani; Letizia Porcelli; Amalia Azzariti; Gabriella Guida
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.